Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors

Published:2019-12 Issue:12 Volume:27 Page:2195-2212
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Li Chang,Mishra Arpit Suresh,Gil Sucheol,Wang Meng,Georgakopoulou Aphrodite,Papayannopoulou Thalia,Hawkins R. David,Lieber André

Funder

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference60 articles.

1. Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives;Naldini;EMBO Mol. Med.,2019

2. HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications;Wang;Genome Res.,2007

3. Genomic safe harbors permit high β-globin transgene expression in thalassemia induced pluripotent stem cells;Papapetrou;Nat. Biotechnol.,2011

4. Use of adeno-associated virus as a general transduction vector for mammalian cells;Muzyczka;Curr. Top. Microbiol. Immunol.,1992

5. Integration preferences of wildtype AAV-2 for consensus rep-binding sites at numerous loci in the human genome;Hüser;PLoS Pathog.,2010

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An induced pluripotent stem cell line carrying a silencing-resistant calcium reporter allele;Stem Cell Research;2024-09

2. Auto-expansion of in vivo HDAd-transduced hematopoietic stem cells by constitutive expression of tHMGA2;Molecular Therapy - Methods & Clinical Development;2024-09

3. Adenoviral vectors infect B lymphocytes in vivo;Molecular Therapy;2023-09

4. Stable HIV decoy receptor expression after in vivo HSC transduction in mice and NHPs: Safety and efficacy in protection from SHIV;Molecular Therapy;2023-04

5. CRISPR medicine for blood disorders: Progress and challenges in delivery;Frontiers in Genome Editing;2023-01-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3